Patient and physician determinants of implantable cardioverter defibrillator use in the heart failure population

Congestive Heart Failure

Volumn 16, Issue 4, 2010, Pages 141-146

  Chae, Sanders H ^a   Koelling, Todd M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; DEFIBRILLATOR; DEMENTIA; DIASTOLIC BLOOD PRESSURE; FEMALE; GROUPS BY AGE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PHYSICIANS; PRIMARY PREVENTION; REGRESSION ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955149869     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00139.x     Document Type: Article

References (9)

1. Moss AJ, Zareba W, Hall WJ. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002, 346(12):877-883.
2. Bardy GH, Lee KL, Mark DB. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005, 352(3):225-237.
3. Epstein AE, DiMarco JP, Ellenbogen KA. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation. 2008, 117(21):2820-2840.
4. Hernandez AF, Fonarow GC, Liang L. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007, 298(13):1525-1532.
5. Fonarow GC, Yancy CW, Albert NM. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008, 1(2):98-106.
6. Curtis LH, Al-Khatib SM, Shea AM. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007, 298(13):1517-1524.
7. Shah B, Hernandez AF, Liang L. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure. JACC. 2009, 53(5):416-422.
8. Cleland JCF, Daubert JC, Erdmann E. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005, 352(15):1539-1549.
9. Bristow MR, Saxon LA, Boehmer J. Cardiac-resynchronization with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004, 350(21):2140-2150.